Cutting Edge: NLRC5-Dependent Activation of the Inflammasome by Davis, Beckley K. et al.
NLRC5-dependent activation of the inflammasome
Beckley K. Davis*, Reid A. Roberts†, Max T. Huang‡, Stephen B. Willingham*,**, Brian J.
Conti*,††, W. June Brickey†, Brianne R. Barker*, Mildred Kwan||, Debra J. Taxman†, Mary-
Ann Accavitti-Loper#, Joseph A. Duncan*,§,¶, and Jenny P-Y. Ting*,†,§§
*Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel
Hill, NC 27599-7295
†Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel
Hill, NC 27599-7295
‡Curriculum in Oral Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC
27599-7295
§Department of Medicine, Division of Infectious Disease, University of North Carolina at Chapel
Hill, Chapel Hill, NC 27599-7295
¶Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC
27599-7295
||Department of Medicine, Division of Rheumatology, Allergy and Immunology, University of North
Carolina at Chapel Hill, Chapel Hill, NC 27599-7295
#University of Alabama at Birmingham, Birmingham, AL
Abstract
The nucleotide-binding domain (NBD) leucine rich repeat (LRR) containing proteins, NLRs, are
intracellular sensors of PAMPs and DAMPs. A subgroup of NLRs can form inflammasome
complexes, which facilitate the maturation of pro-caspase-1 to caspase-1, leading to IL-1β and
IL-18 cleavage and secretion. NLRC5 is predominantly expressed in hematopoetic cells and has
not been studied for inflammasome function. RNAi-mediated knockdown of NLRC5 nearly
eliminated caspase-1, IL-1β and IL-18 processing in response to bacterial infection, PAMPs and
DAMPs. This was confirmed in primary human monocytic cells. NLRC5 together with
procaspase-1, pro-IL-1β and the inflammasome adaptor, ASC, reconstituted inflammasome
activity which showed cooperativity with NLPR3. The range of pathogens that activate NLRC5
inflammasome overlaps with those that activate NLRP3. Furthermore, NLRC5 biochemically
associates with NLRP3 in an NBD-dependent but LRR-inhibitory fashion. These results invoke a
model where NLRC5 interacts with NLRP3 to cooperatively activate the inflammasome.
Introduction
The role of NLRC5 is controversial and unresolved. Five recent publications have offered
conflicting and alternating roles of NLRC5 in innate and adaptive immunity (1–5). One
view suggests that NLRC5 is a positive regulator of the interferon pathway in HeLa and
THP-1 cells and is required for robust levels of interferon secretion(3, 5). However, Benko
et. al. demonstrated that NLRC5 is a negative regulator of the interferon, NF-κB and AP-1
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pathways in 293 cells. Furthermore, in mouse monocytic cell line RAW 264.7 cells, Nlrc5
functioned in an inhibitory manner. Cui et. al. provided mechanistic detail by demonstrating
that Nlrc5 interacts with IKKα and inhibits its catalytic activity. Therefore in its absence
there is a more robust proinflammatory response characterized by increased levels of TNF-
α, IL-6 and IL-1β. NLRC5 has also been shown to positively regulate MHC class I gene
expression by directly binding to the promoter region of MHC class I and associated genes
in 293T cells(4). However, an opposite effect has been described in RAW 264.7 cells, as
RNAi-mediated knock down on Nlrc5 induced MHC class I expression(1). Therefore a
complex and either cell type or species specific role for NLRC5 is emerging. However, none
of the published studies investigated a role of NLRC5 in inflammasome function or
formation.
In this study, we delineated a new function for NLRC5 in inflammasome formation in
response to pathogens, PAMPs or DAMPs. In the absence of NLRC5, macrophage cell
types process proIL–1β and proIL-18 ineffectively and activation of caspase-1 is nearly
eliminated in response to NLRP3- specific agonists. Finally, we demonstrate that NLRC5
associates with itself and NLRP3. These data suggest NLRC5 is a novel NLR protein that
cooperates with NLRP3 to induce inflammasome formation.
Materials and Methods
Quantitative PCR analysis of NLRC5 expression
Human total RNA Master Panel II (Clontech) and mouse tissue RNA was used for cDNA
synthesis using standard procedures. Quantitative PCR was performed with pre-validated
NLRC5 primers (Applied Biosystems). Transcripts were calculated by ΔΔCt method or
relative expression by Gapdh, Actin or 18s rRNA. Microarray data was mined from the
Genomics Institute of the Novartis Research Foundation (http://biogps.gnf.org/).
Inflammasome related genes were cloned from THP-1 mRNA with primers designed to
amplify the ORFs.
Cell culture
The human monocytic cell line THP-1 was transduced with shRNA (supplemental table 1)
containing lentivirus. Knock-down efficacies were determined by immunoblot analysis. 2 ×
106 cells were transfected by amaxa with 20–200pMoles of siRNA (Ambion) and protocols
T008 (THP-1) or V001 (monocytes).
Bacteria
S. flexneri (strain 12022), K. pneumoniae (strain 43816 serotype 2), P. gingivalis (strain
A7436) and L. monocytogenes (strain 43251) were obtained from ATCC and cultured as
directed. E. coli (strain LF82) was provided by Dr. R. Sartor. (UNC at Chapel Hill) and S.
aureus (strain RN6390) from J.A.D.
Infections and stimulations
THP-1 cells were harvested in log phase growth. Bacteria were grown to stationary phase
overnight. Cultures were diluted 1:250 and grown for an additional 2hrs then quantitated by
optical density. Co-cultures were pulsed with gentamicin at 50μg/ml (Gibco) after 1hr.
Infections were harvested after an additional 2hrs. Student T-tests were performed to
determine significance. For PAMP stimulation, cells were plated and stimulated with
indicated PAMPs (Invivogen) overnight. For monosodium urate (MSU) (Invivogen) and
alum (Sigma) cells were primed with 5ng/ml of ultrapure LPS from E. coli for 2hrs then
pulsed with agonist for an additional 4–6hrs. For nigericin (Invivogen), α-hemolysin (J.A.D)
stimulation cells primed as before but harvested after 2hrs.
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Cytokine, immunoblot and cell death analyses
IL-1β, IL-18 and TNF-α were measured by ELISA (BD Biosciences and Binder Life
Sciences). Immunoblot were performed as described and probed with anti-IL-1β antibodies
from Cell Signaling (#2022 and #2021) and Santa Cruz Biotechnology (sc-52865)(6). Cell-
free supernatants were used to quantitate cell death by ToxiLight® bioassay (Lonza)(7).
Immunoprecipitations
HEK293T cells were transfected with Lipofectamine 2000 (Invitrogen) or Fugene6 (Roche)
at a ratio of 3:1 (Lipid:DNA). Cells were lysed in RIPA buffer in the presence of protease
inhibitors and Benzoase (Novagen). IPs were washed with 1ml of RIPA buffer 5 times then
resolved on 4–12% Bis-Tris gels. Immunoblots were probed with HRP-conjugated M2
(Sigma), anti-HA (Roche), anti-V5 (Invitrogen) antibodies.
Results
Expression, cloning and characterization of NLRC5
NLRC5 is expressed predominantly in the lymphocytic and macrophage/monocytic cell
lineages with low expression in non-hematopoetic cells based on public gene profile
database (S Fig1A and C). By real-time PCR analysis of human and mouse tissues (S Fig.
1B and D), NLRC5 is expressed preferentially in immune tissues relative to non-immune
tissues. The gene is encoded by 49 exons and its ORF is 5601 nucleotides (46 exons)(8).
NLRC5 has an N-terminal CARD-like domain and an extended C-terminus consisting of an
expanded LRR, making it the largest member of the NLRs (S Fig. 2A) with an approximate
molecular weight of 200kDa compared to the molecular weights of other NLRs ~100kDa
each. NLRC5 is well conserved in vertebrate evolution; orthologs can be found in human,
chimpanzee, cow, rat and mouse (S Fig. 2B)(9). Thus NLRC5 is a conserved NLR member
with preferential expression in hematopoetic cells.
NLRC5-dependent inflammasome activation
We explored the role of NLRC5 in monocytic cells due to their prominent role in innate
immunity and inflammation. Its role in inflammasome activation was studied using sh- and
siRNA to reduce its expression in the THP-1 monocytic cell line. ShRNA for NLRP3 and
ASC served as positive controls. Due to the potential off-target effects of shRNA, a panel of
shRNA target sequences to NLRC5 (shNLRC5) and shRNA controls in lentiviral constructs
was tested. ShNLRC5 effectively reduced endogenous levels NLRC5 transcript (S fig. 3A)
and protein (S fig. 3B). The former was determined using three primer sets and the latter
was determined by immunoblot using a mAb specific for the N-terminus of NLRC5 (S Fig.
3C–D). E. coli infected cells with shNLRC5 produced significantly reduced levels of
secreted IL-1β compared to cells with control shRNAs in two different lentivirus vectors
(Fig. 1A–B and S Fig. 3E). To avoid potential effects of lentiviral transduction, THP-1 cells
were also transiently transfected with siRNA oligonucleotides (siNLRC5 and siNLRP3).
Cells with control siRNA (siControl) secreted significantly more IL-1β than cells with either
siNLRC5 or siNLRP3 upon E. coli infection (Fig. 1C). Importantly, human primary
monocytes from two anonymous donors transfected with siRNA oligonucleotides specific
for NLRC5 also failed to mount robust IL-1β in response to E. coli (Fig. 1D). IL-1β
processing (Fig. 1E) and caspase-1 (Fig. 1F) maturation are also greatly reduced in the
absence of NLRC5. Real time PCR analysis demonstrates that in the absence of NLRC5,
transcription of NLRP3 and ASC are unaffected (S Fig. 4A–C). Additionally pro-IL-1β
levels are comparable (S Fig. 4D). These data suggest that NLRC5 has a role in IL-1β
inflammasome formation in transformed and non-transformed human monocytic cells.
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NLRC5-dependent response to pathogens
To determine the specificity of signals that activate the NLRC5-dependent inflammasome,
THP-1 cell lines stably expressing shNLRC5 or control shRNA were infected with a panel
of bacteria. Candidate pathogens E. coli, S. flexneri and S. aureus require NLRP3 and ASC
to activate the inflammasome (Fig. 2A–C) and they also induced significantly less IL-1β
secretion in cells expressing shNLRC5 relative to cells expressing shControl. The decrease
in IL-1β and IL-18 with different bacteria was observed over various concentrations (S Fig.
5A–D) except at high concentrations of S. aureus, IL-1β/IL-18 secretion is independent of
NLRC5 (S Fig. 5B, D). These data suggest that NLRC5 modulates inflammasome activation
to a wide array of bacterial pathogens.
NLRC5 is required for inflammasome activation by PAMPs, DAMPs and toxins
To further dissect possible agonists that activate the NLRC5 inflammasome, THP-1 cells
with shNLRC5 or control shRNA were stimulated with pathogen-associated molecular
patterns (PAMPs), damage-associated molecular patterns (DAMPs) and pore-forming
toxins, all of which can activate the NLRP3 inflammasome, possibly via the release of
endogenous secondary signals such as ATP or reactive oxygen species . The PAMPs induce
significantly less IL-1β in the absence of NLRC5 (Fig. 2D). Treatment with MSU or alum
crystals also induces IL-1β secretion in an NLRC5-dependent fashion (Fig. 2D). Nigericin
from Streptomyces hygroscopicus and α-hemolysin from S. aureus activate the NLRP3
inflammasome by pore-formation(6, 10, 11). Interestingly, IL-1β secretion in response to
these toxins is independent of NLRC5 (Fig. 2E). These data revealed that NLRC5 is not
required for inflammasome activation by the pore-forming toxins tested. The fact that
purified S. aureus α-hemolysin induces NLRC5-independent IL-1β production is
compatible with earlier results showing that high MOIs of S. aureus causes NLRC5-
independent inflammasome activation and is consistent with α-hemolysin being a
synergistic but not sole mechanism for robust IL-1β secretion(6, 11). These findings suggest
that inflammasome activation by bacterial PAMPs and crystals, but not pore-forming toxins,
requires NLRC5.
NLRC5-independent regulation of TNF-α and cell death
To assess the specificity of NLRC5 function, we assayed supernatants from bacteria-
infected cells for TNF-α. TNF-α levels from shNLRC5-containing cells are not
significantly different from control cell lines after infection with bacteria (Fig. 2F).
Pathogen-mediated activation of caspase-1 and/or NLRs can induce several cell death
pathways that are broadly characterized as proinflammatory since they result in the further
release of inflammatory molecules(12, 13). Interestingly, pathogen-induced cell death that
are documented to require NLRP3 in THP-1 cells is not affected by the absence of NLRC5
(Fig. 2G), suggesting that the function of NLRC5 is more restricted to inflammasome
activation.
Interactions of NLRC5 with NLRP3 and ASC but not other inflammasome components
The overlapping biologic functions and pathogen-specificity of NLRC5 with NLRP3
suggests that these proteins might act in a cooperative manner during the inflammasome
assembly of ASC, NLRP3, and caspase-1. To test if NLRC5 interacts with inflammasome
components we performed co-immunoprecipitation experiments with NLRC5 and itself,
NLRP3, AIM2, ASC, procaspase-1 and proIL-1β. Epitope-tagged NLRC5 interacts with
itself, NLRP3 and ASC (Fig. 3A and S Fig 6A). In contrast, it did not interact with the other
inflammasome components AIM2, procaspase-1, proIL-1β nor additional cytosolic proteins
such as TRAF2, JNK (S Fig. 6B–C). To determine if the interactions of NLRC5 are specific
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to inflammasome-forming NLRs, we show that NLRC5 does not interact with another NLR,
CIITA (S Fig. 6D)
To determine the domain of NLRC5 that is necessary and sufficient for NLRP3 binding,
truncation mutants were used in co-immunoprecipitation experiments (Fig. 3B). The NBD
domain appears to be necessary and sufficient to bind NLRP3, as it co-immunoprecipitates
with NLRP3. The N-terminal CARD (N-term) or C-terminal LRR (LRR) of NLRC5 failed
to co-immunoprecipitate with NLRP3. The presence of the N-terminus to the NBD domain
in the N-NBD construct did not influence the binding capacity of the NBD. However the
presence of LRR in the NBD-LRR construct reduced interaction with NLRP3. This result
agrees with general concept that the LRR is inhibitory in function. To note, we have
consistently observed decreased levels of NLRP3 in the presence of the LRR of NLRC5 and
are currently investigating this phenomenon.
Others have demonstrated that reconstitution of inflammasome components in epithelial
cells can lead to spontaneous or PAMP-induced IL-1β processing(14). To test whether
NLRC5 can facilitate inflammasome function, we transfected these inflammasome
components into HEK293T cells and measured IL-1β processing. Transient transfection
with NLRC5, procaspase-1, proIL-1β and ASC results in IL-1β processing that was
dependent on the inflammasome component expression as measured by secreted IL-1β (Fig.
3C). The level of IL-1β induced by the non-inflammasome NLR protein NOD1 is
significantly less than the amount seen with NLRC5. When NLRC5 was co-transfected with
increasing amounts of NLRP3 or vice versa, a synergistic increase in IL-1β secretion is
observed (Fig. 3D). These data suggest that NLRC5 is a component of the inflammasome in
a reconstituted and ectopic system either by itself or in conjunction with NLRP3.
Discussion
Inflammasome activation represents a major function of some NLR proteins(15) although
the function of a majority of NLR proteins remains unclear. NLRC5 is primarily expressed
in adaptive and innate immune system. The conserved expression pattern of NLRC5
orthologs suggests a critical biological role in immunity. As its expression in monocytic
cells might be indicative of a role in innate immunity to pathogens, we examined the role of
NLRC5 in inflammasome function. We now describe NLRC5 as a critical component of
inflammasome-dependent IL-1β secretion in response to a repertoire of stimuli that also
activate NLRP3. This function is supported by the interactions of NLRC5 with NLRP3 and
ASC as well as its ability to form inflammasome complexes in an ectopic system. These
interactions might greatly increase the repertoire of biological moieties that can be sensed by
NLR inflammasomes as has been previously predicted(9).
In THP-1 cells infected with higher concentrations of S. aureus or stimulated with purified
α-hemolysin, secretion of IL-1β is independent of NLRC5. S. aureus is known to elaborate
many pore-forming and immune-modulating toxins. Thus at high concentrations it is
possible that these toxins activate an NLRC5-independent but NLRP3-dependent
inflammasome. Interestingly, many of these toxins disrupt the cell membrane and ultimately
induce cell death. In our studies NLRC5 appears to be dispensable in pathogen-induced cell
death, while NLRP3(7) is essential. This divergence of function may signify segregation
between multiple pathways.
The mechanisms that govern pathogen-induced inflammasome activation remain poorly
characterized and the contribution of individual NLRs is controversial. For example, early
studies demonstrated an absolute role for Nlrc4 in Salmonella-dependent IL-1β
secretion(10); however recent studies have challenged the notion that IL-1β secretion relies
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exclusively upon Nlrc4(16). Similarly, Miao et al. has recently demonstrated Nlrc4-
dependent inflammasome activation in response to components of the type 3 secretion
system in a broad panel of Gram-negative bacteria. Likewise, there is controversy over the
role of Nlrp3- and Nlrc4-dependent inflammasome activation in response to S. flexneri
infection(7, 17). These differences might reflect differences in bacterial strains, host species,
infected cell types or duration and multiplicities of infection. Notwithstanding, the mounting
evidence suggests that during bacterial infections multiple NLR inflammasomes have the
potential to become activated.
NLRs have been shown to have different roles in separate cell types(18). A prime example
is NOD2, which was initially described as an epithelial cell and/or macrophage sensor of
MDP that induces NF-κB activation(19, 20). Others have shown that NOD2 functions as an
inflammasome component that facilitates NLRP1-dependent activation in monocytic
cells(21). The multiple functions of NLRs are also illustrated in the analysis of NLRC5.
NLRC5 is reported to have a positive role in antiviral immunity in a human epithelial cell
lines and primary fibroblasts(3, 5), and as a negative regulator of both type I interferon and
NF-κB-dependent cytokines via interactions in epithelial and monocytic cells(1, 2), and as a
positive regulator of MHC class I gene transcription in human cells(4) but not mouse cell
lines(1). Our data demonstrate a separate function of NLRC5 in monocytic cells. Whether
these diverse functions relate to the unique structure of NLRC5 or the biological systems
used remains to be seen. The generation of mice deficient in Nlrc5 might shed light on the in
vivo role of this gene.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. NLRC5 is necessary for inflammasome activation in response to E. coli
A) Lentivirus transduced THP-1 cells were stimulated with E. coli. Cell supernants were
assayed for IL-1β by ELISA. Two shNLRC5 and their control shRNA with sequence
specific mutations (shControl1 and shControl2) were analyzed. B) ShRNA containing
Control cell lines were assayed for IL-1β secretion in response to E. coli: shEV = empty
vector; shLuc = shRNA to luciferase; mshASC = mutant ASC; mshNLRC5 = mutant
shNLRC5#1; shASC, shNLRP3, shNLRC5 = sequence specific shRNA. C) THP-1 cells
were nucleofected with siRNAs specific for NLRP3 and NLRC5 and with a non-silencing
(siControl) control siRNA, 48 hours cells were stimulated as in (A). D) Human primary
monocytes were transfected with siRNA to NLRC5 and a non-silencing siRNA (siControl)
and stimulated as in (C). In D) values were normalized to non-silencing control. In A-C)
experiments were repeated at least three independent times. Untreated samples were below
the level of detection. Asterisks denote p < 0.05. (E) THP-1 cell lysates were probed for
active IL-1β in response to E. coli infection and active capase-1 (F).
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Figure 2. NLRC5 is necessary for IL-1β production in response to bacterial pathogens and
DAMPs
A) E. coli (MOI of 5) B) S. aureus (MOI 5) C) S. flexneri (MOI 5) D) were used to infect
THP-1 cell lines. Cell-free supernatants were analyzed for IL-1β. Asterisks denote p < 0.05.
D-E) THP-1 cells were stimulated with PAMPs and DAMPs. Untx = untreated; LPS =
lipopolysaccharide; LTA = lipoteichoic acid; Lman = lipomannan; FSL = FSL-1; P3Cys =
Pam3Cys; MSU = monosodium urate and Alum. Cell-free supernatants were harvested and
assayed for IL-1β. E) and treated with nigericin (40μM) and α-hemolysin 1μg/ml(αHL). F)
TNF-α secretion in response to pathogenic bacteria infection. G) Cell death measured by
release of ATP by Toxilight assay during infection with high (50) and low (5) MOIs. Values
represent mean ±standard deviation of duplicate samples. All experiments were done at least
three individual times.
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Figure 3. NLRC5 interacts with inflammasome components
A) FLAG™ tagged NLRP3 and ASC were co-transfected with NLRC5-V5. Lysates were
immunoprecipitated with α-V5 and probed with α-FLAG™ mAbs. NLRC5 specifically
interacts with NLRP3 and ASC. B). Truncation mutants of NLRC5 were co-transfected with
NLRP3-FLAG. Lyastes were immunoprecipated with α-V5 mAb and probed with α-
FLAG™. C). HEK293T cells were transfected with caspase-1 and IL-1β in the presence of
increasing amounts of ASC in the presence or absence of NLRs. Supernatants were analyzed
for IL-1β by ELISA. D) HEK293T cells were transfected with increasing concentrations of
NLRP3 or NLRC5 in the presence of ASC, pro-caspase-1 and –IL-1β. Cell lysates were
probed for cleaved IL-1β.
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